Literature DB >> 24371402

Elevated KAI1 Protein Expression Identified in Malignant Melanoma.

Moon-Kyun Cho1.   

Abstract

Entities:  

Year:  2013        PMID： 24371402      PMCID： PMC3870223          DOI： 10.5021/ad.2013.25.4.498

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  8 in total

1.  KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.

Authors:  X Z Guo; H Friess; C Maurer; P Berberat; W H Tang; A Zimmermann; M Naef; H U Graber; M Korc; M W Büchler
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

2.  Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.

Authors:  J Geradts; R Maynard; M J Birrer; D Hendricks; S L Abbondanzo; K M Fong; J C Barrett; D P Lombardi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin.

Authors:  H Okochi; M Kato; K Nashiro; O Yoshie; K Miyazono; M Furue
Journal:  Br J Dermatol       Date:  1997-12       Impact factor: 9.302

4.  Genomic organization of the human KAI1 metastasis-suppressor gene.

Authors:  J T Dong; W B Isaacs; J C Barrett; J T Isaacs
Journal:  Genomics       Date:  1997-04-01       Impact factor: 5.736

5.  Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer.

Authors:  Y Hinoda; Y Adachi; A Takaoka; H Mitsuuchi; Y Satoh; F Itoh; Y Kondoh; K Imai
Journal:  Cancer Lett       Date:  1998-07-17       Impact factor: 8.679

6.  Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.

Authors:  Maria V Yusenko; Gyula Kovacs
Journal:  Histopathology       Date:  2009-12       Impact factor: 5.087

7.  Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.

Authors:  Ross D Farhadieh; Robert Smee; Kim Ow; Jia Lin Yang; Pamela J Russell; Roger Crouch; Paul Jackson; Ian V Jacobson
Journal:  Cancer Lett       Date:  2004-09-15       Impact factor: 8.679

8.  CD82, and CD63 in thyroid cancer.

Authors:  Zhouxun Chen; Tarek Mustafa; Bogusz Trojanowicz; Michael Brauckhoff; Oliver Gimm; Cornelia Schmutzler; Josef Köhrle; Hans-Jürgen Holzhausen; Astrid Kehlen; Thomas Klonisch; Rainer Finke; Henning Dralle; Cuong Hoang-Vu
Journal:  Int J Mol Med       Date:  2004-10       Impact factor: 4.101
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.